Regeneron Pharmaceuticals, Inc.
Close on Nov 18, 2026Market cap $97.81BP/E 20.9Yield –
Regeneron Pharmaceuticals Customer Revenue Concentration by Quarter
Customer Revenue Concentration — McKesson Corporation Share of Gross Product Revenue (%) (%)
Regeneron Pharmaceuticals Customer Revenue Concentration: 3,000.0% in Q3 2026, unchanged from a year earlier.
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-10-30) ↗
Reported in Form 10-Q / 10-K Note — Concentration of Credit Risk (XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Customer Revenue Concentration — McKesson Corporation Share of Gross Product Revenue (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 3,000.0% | 0.0 pts | Form 10-Q (filed 2026-10-30) ↗ |
| Q2 2026 | Jun 30, 2026 | 3,200.0% | +800.0 pts | Form 10-Q (filed 2026-07-30) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,000.0% | +500.0 pts | Form 10-Q (filed 2026-04-29) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,000.0% | +600.0 pts | Form 10-Q (filed 2026-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,400.0% | 0.0 pts | Form 10-Q (filed 2026-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,500.0% | +100.0 pts | Form 10-Q (filed 2026-04-29) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,400.0% | 0.0 pts | Form 10-Q (filed 2025-10-28) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,400.0% | -100.0 pts | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,400.0% | -100.0 pts | Form 10-Q (filed 2025-04-29) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,400.0% | -400.0 pts | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,500.0% | -300.0 pts | Form 10-Q (filed 2024-08-01) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,500.0% | -500.0 pts | Form 10-Q (filed 2024-05-02) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,800.0% | +400.0 pts | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,800.0% | +1400.0 pts | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2022 | Mar 31, 2022 | 3,000.0% | +100.0 pts | Form 10-Q (filed 2023-05-04) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,400.0% | -1000.0 pts | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,400.0% | -1800.0 pts | Form 10-Q (filed 2022-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 2,900.0% | -700.0 pts | Form 10-Q (filed 2022-05-04) ↗ |
| Q3 2020 | Sep 30, 2020 | 3,400.0% | 0.0 pts | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 3,200.0% | -200.0 pts | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 3,600.0% | +500.0 pts | Form 10-Q (filed 2021-05-06) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,400.0% | -200.0 pts | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,400.0% | -100.0 pts | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 3,100.0% | -900.0 pts | Form 10-Q (filed 2020-05-05) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,600.0% | +700.0 pts | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2018 | Jun 30, 2018 | 3,500.0% | +600.0 pts | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 4,000.0% | +1300.0 pts | Form 10-Q (filed 2019-05-07) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,900.0% | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,900.0% | – | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,700.0% | – | Form 10-Q (filed 2018-05-03) ↗ |
Cite this data
StockData. (2026). Regeneron Pharmaceuticals Customer Revenue Concentration (%), quarterly Q1 2017–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/conc-mckesson-rev
See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?